In this study, we identified gene expression changes in response to pathogenic variants in MBTPS2 causing either OI or IFAP/KFSD through RNA-sequencing-based transcriptome profiling of fibroblasts obtained from patients and healthy donors. This evidence concerns the gene MBTPS2 and osteogenesis imperfecta.